[EN] N-ARYL-2-OXAZOLIDINONE-5-CARBOXAMIDES AND THEIR DERIVATIVES AND THEIR USE AS ANTIBACTERIALS [FR] N-ARYL-2-OXAZOLIDINONE-5-CARBOXAMIDES ET LEURS DERIVES ET UTILISATION DE CES COMPOSES COMME ANTIBACTERIENS
Discovering Potent Small Molecule Inhibitors of Cyclophilin A Using de Novo Drug Design Approach
摘要:
This work describes an integrated approach of de novo drug design, chemical synthesis, and bioassay for quick identification of a series of novel small molecule cyclophilin A (CypA) inhibitors (1-3). The activities or the two most potent CypA inhibitors (3h and 3i) are 2.59 and 1.52 nM, respectively, which are about 16 and 27 times more potent than that of cyclosporin A. This study clearly demonstrates the power of our de novo drug design strategy and the related program LigBuilder 2.0 in drug discovery.
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
申请人:——
公开号:US20040147760A1
公开(公告)日:2004-07-29
The present invention provides antibacterial agents having the formulae I, II, and III described herein.
本发明提供了具有以下式I、II和III的抗菌剂。
Process for preparing amines
申请人:——
公开号:US05410082A1
公开(公告)日:1995-04-25
Process for preparing amines by reacting amides in aqueous-alkaline solutions and/or suspensions with halogens or hypohalites in the presence of alcohols, and converting the reaction products into the amines by hydrolysis, hydrogenation or reductive methods.
A compound which may be used for the prevention or treatment of respiratory diseases in which STAT 6 is concerned, particularly asthma, chronic obstructive pulmonary disease and the like is provided. A pyrimidine derivative or a salt thereof, which has an arylamino or arylethylamino group which may be substituted with a specified substituent, at the 2-position, amino group substituted with benzyl group or the like, at the 4-position, and carbamoyl group which may be substituted, at the 5-position, is provided.
N-Aryl-2-oxazolidinone-5-carboxamides and their derivatives
申请人:——
公开号:US20040044052A1
公开(公告)日:2004-03-04
The present invention provides antibacterial agents having the formulae I, II, and III described herein.
本发明提供了具有以下公式I、II和III的抗菌剂。
Diaminopyrimidinecarboxamide Derivative
申请人:Nagashima Shinya
公开号:US20090281072A1
公开(公告)日:2009-11-12
A compound which may be used for the prevention or treatment of respiratory diseases in which STAT 6 is concerned, particularly asthma, chronic obstructive pulmonary disease and the like is provided.
A pyrimidine derivative or a salt thereof, which has an arylamino or arylethylamino group which may be substituted with a specified substituent, at the 2-position, amino group substituted with benzyl group or the like, at the 4-position, and carbamoyl group which may be substituted, at the 5-position, is provided.